News Posts List
Exelixis Drug Slows Kidney Cancer
07/21/2015
Those impressive reductions in death are still only likely to mean that Cometriq gave patients, on average, a few more months of life.
Potential therapeutic target in renal cell carcinoma
07/17/2015
Axl plays multiple roles in tumourigenesis in several cancers. Here we evaluated the expression and biological function of Axl in renal cell carcinoma (RCC).
Argos fully enrolls its trial to test a cancer therapy
07/16/2015
Argos is developing a therapy to treat metastatic renal cell carcinoma (mRCC) and hit the enrollment goal of 450 randomized patients. This is a Phase 3 trial, meaning it is one of the last major steps a drug developer takes before submitting an application with the U.S. Food and Drug Administration.
New surgical technique preserves kidney function following tumour removal
07/14/2015
Patients benefit twice from the new technique: during the operation itself, the risk of bleeding and complications is lower. In the long term, renal function is preserved and there are no long-term consequences of renal impairment.
Penn State Uplifting Athletes raises $120,000 at Lift for Life
07/14/2015
The 13-year total for “Lift for Life” is now more than $1.12 million. More than 100 members of the Nittany Lion football team participated in Saturday's Lift For Life.
Kidney Cancer Association - Urology Care Foundation Research Scholar Award
07/10/2015
Project Title: "Interrogation of the Sorbitol Pathway in VHL-Independent HIF driven Renal Cell Carcinomas"
Xp11.2 translocation renal cell carcinomas in young adults
07/01/2015
Little is known about the biological behavior of Xp11.2 translocation renal cell carcinomas (RCCs) as few clinical studies have been performed using a large sample size.
Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma
06/28/2015
The renin-angiotensin system may play a role in carcinogenesis. The purpose of this study was to evaluate the impact of angiotensin system inhibitors (ASI) on outcomes in metastatic renal cell carcinoma (mRCC) patients treated in the targeted therapy era.
Penn State’s annual Lift for Life set
06/26/2015
The event will include the Penn State offense facing the defense in a series of competitions to benefit the Kidney Cancer Association.
PRednisone Plus EVerolimus clinical trial
06/25/2015
Title Phase II study of oral PRednisone 5 mg bid plus EVerolimus in patients with metastatic renal cell cancer after failure of vascular endothelial growth factor receptor-tyrosine kinase inhibitor (PREV study).
News Feed